Botulinum Toxin-A Injections Into Neurogenic Overactive Bladder-To Include or Exclude the Trigone? A Prospective, Randomized, Controlled Trial

被引:56
|
作者
Abdel-Meguid, Taha A. [1 ,2 ]
机构
[1] King Abdulaziz Univ Med City, Dept Urol, Jeddah, Saudi Arabia
[2] Menia Univ, Dept Urol, El Minia, Egypt
来源
JOURNAL OF UROLOGY | 2010年 / 184卷 / 06期
关键词
urinary bladder; neurogenic; spinal cord injuries; botulinum toxin type A; urinary incontinence; urodynamics; IDIOPATHIC DETRUSOR OVERACTIVITY; INTRADETRUSOR INJECTIONS; INCONTINENCE; STANDARDIZATION; TERMINOLOGY;
D O I
10.1016/j.juro.2010.08.028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The short-term outcomes of initial detrusor injections vs combined detrusor-trigone botulinum toxin-A injections were determined in patients with spinal cord injury-neurogenic detrusor overactivity. Materials and Methods: Adults with refractory spinal cord injury-neurogenic detrusor overactivity who strictly discontinued anticholinergics were recruited for the study. At a 1: 1 ratio patients randomly received 300 U botulinum toxin-A intradetrusor injections excluding the trigone (detrusor arm) or 200 U intradetrusor plus 100 U intratrigonal injections (combined arm). Study end points were determination of the impact on incontinence episodes, complete dryness, quality of life, reusing anticholinergics, maximum detrusor pressure, reflex volume, maximum cystometric capacity, vesicoureteral reflux and adverse events. Patients were evaluated at baseline, and 2, 8, 12 and 18 weeks after injection. Statistical significance was considered at p<0.05. Results: Analysis included 18 patients per arm with no significant baseline differences. On within group analysis all parameters improved significantly compared to baseline. On between group analysis in the detrusor vs the combined arm at week 8 incontinence decreased by 52.4% vs 80.9% (number needed to treat 1.91 vs 1.23 patients, p<0.001), complete dryness was achieved in 33.3% vs 66.7% of patients (number needed to treat 3 vs 1.5, p<0.001) and quality of life score was decreased by 46.76% vs 48.13% (number needed to treat 2.14 vs 2.08, p<0.44). The absolute difference was 60% vs 82.5% for reflex volume (p<0.001), 66.2% vs 68.4% for maximum cystometric capacity (p<0.22) and -42.3% vs -41.9% for maximum detrusor pressure (p<0.21). At week 18 anticholinergics were needed again in 9 (50%) and 4 patients (22.2%) patients, respectively. No patient showed new or upgraded vesicoureteral reflux or reported significant adverse events. Conclusions: In the short term all parameters improved significantly in each arm. The superiority of including rather than excluding the trigone was significant.
引用
收藏
页码:2423 / 2428
页数:6
相关论文
共 50 条
  • [1] Botulinum toxin into the trigone in neurogenic overactive bladder non responder to detrusor injection
    Spinelli, M.
    Citeri, M.
    Zanollo, L.
    Macrellino, E.
    Redaelli, T.
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (05) : 734 - 734
  • [2] Botulinum Toxin A Injections for Non-neurogenic Overactive Bladder
    Kuo H.-C.
    Current Bladder Dysfunction Reports, 2014, 9 (3) : 254 - 260
  • [3] Botulinum toxin-A (Botox®) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: A systematic literature review
    Game, Xavier
    Mouracade, Pascal
    Chartier-Kastler, Emmanuel
    Viehweger, Elke
    Moog, Raphael
    Amarenco, Gerard
    Denys, Pierre
    De Seze, Marianne
    Haab, Francois
    Karsenty, Gilles
    Kerdraon, Jacques
    Perrouin-Verbe, Brigitte
    Ruffion, Alain
    Soler, Jean-Marc
    Saussine, Christian
    JOURNAL OF PEDIATRIC UROLOGY, 2009, 5 (03) : 156 - 164
  • [4] A botulinum toxin into the trigone in neurogenic overactive bladder non-responder to detrusor injection
    Citeri, M.
    Spinelli, M.
    Zanollo, L.
    Scroppo, F.
    Macrellino, E.
    Redaelli, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 213 - 213
  • [5] Intradetrusor botulinum toxin injections for neurogenic overactive bladder: Are we there yet?
    Lemack, Gary E.
    EUROPEAN UROLOGY, 2008, 53 (02) : 240 - 241
  • [6] Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
    Cohen, Brian L.
    Caruso, Daniel J.
    Kanagarajah, Prashanth
    Gousse, Angelo E.
    ADVANCES IN UROLOGY, 2009, 2009
  • [7] Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder
    Bentaleb, Y.
    Castel-Lacanal, E.
    Sallusto, F.
    De Boissezon, X.
    Malavaud, B.
    Marque, P.
    Rischmann, P.
    Game, X.
    PROGRES EN UROLOGIE, 2008, 18 (07): : 449 - 455
  • [8] Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial
    Olesch, Christine A.
    Greaves, Susan
    Imms, Christine
    Reid, Susan M.
    Graham, H. Kerr
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2010, 52 (01): : 79 - 86
  • [9] Efficacy of repeated injections of botulinum toxin-A in patients with overactive bladder and idiopathic detrusor overactivity
    Dowson, Christopher
    Sahai, Arun
    Roux, Jacques
    Watkins, Jane
    Khan, Mohammad S.
    Dasgupta, Prokar
    JOURNAL OF UROLOGY, 2008, 179 (04): : 441 - 441
  • [10] Efficacy of repeated injections of Botulinum Toxin-A in patients with overactive bladder and idiopathic detrusor overactivity
    Dowson, Christopher
    Sahai, Arun
    Watkins, Jane
    Khan, Mohammad S.
    Dasgupta, Prokar
    TOXICON, 2008, 51 : 40 - 40